Segelmark Mårten, Segelmark Leo, Smolander Jessica, Rydell Helena, Evans Marie, Stendahl Maria
professor, överläkare, institutionen för kliniska vetenskaper i Lund, Lunds universitet; VO njurmedicin och reumatologi, Skånes universitetssjukhus.
läkare, forskningsassistent, Svenskt njurregister.
Lakartidningen. 2021 Nov 16;118:21051.
Data from the Swedish Renal Registry (SRR) show that during the period March 16, 2020 to March 15, 2021 0.4% of all renal transplant recipients and 3% of all dialysis patients died due to COVID-19 in Sweden. Of all registered deaths, 20% were attributed to COVID-19. In the age group 50-59 years the risk ratio for COVID-19 related mortality was 16 (95% CI 6.5-38) among transplant recipients and 22 (95% CI 7.1-69) among dialysis patients, compared to the background population in the same age group. Excess mortality, compared to the five years preceding the pandemic, was 30% for transplant recipients and 8.7% for dialysis patients, compared to 7.7% for the entire Swedish population. Detailed reports were sent to SRR for 864 patients with confirmed COVID-19 infection representing 5.0% of all transplant recipients and 13% of all dialysis patients. The case fatality rate was 7.0% and 21% respectively.
瑞典肾脏登记处（SRR）的数据显示，在2020年3月16日至2021年3月15日期间，瑞典所有肾移植受者中有0.4%以及所有透析患者中有3%死于新冠病毒病（COVID-19）。在所有登记的死亡病例中，20%归因于COVID-19。在50-59岁年龄组中，与同年龄组的背景人群相比，肾移植受者中COVID-19相关死亡率的风险比为16（95%置信区间6.5-38），透析患者中为22（95%置信区间7.1-69）。与大流行前的五年相比，肾移植受者的超额死亡率为30%，透析患者为8.7%，而瑞典全体人口为7.7%。代表所有肾移植受者5.0%和所有透析患者13%的864例确诊COVID-19感染患者的详细报告已发送至SRR。病死率分别为7.0%和21%。
